SCHEMBL20733918

SCHEMBL20733918

CCCCSc1ncc(C=O)c(NC)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42
▸ RELA Q04206 1/20 0.42
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ HASPIN Q8TF76 3/20 0.38
▸ PPARG P37231 2/20 0.37
▸ POLB P06746 1/20 0.35
▸ KDM6B O15054 1/20 0.35
▸ KDM4A O75164 1/20 0.35
▸ KDM4D Q6B0I6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4824659 0.81 SMN1; SMN2 (0.55) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL6249823 0.81 NPC1 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL1521592 0.77 LMNA (0.40) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL27627103 0.75 SMN1; SMN2 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL6247194 0.72 LRRK2 (0.31) —
SCHEMBL1014882 0.71 RAB9A (0.42) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL3140746 0.70 XDH (0.39) MEN1KMT2AGAAL3MBTL1POLB
SCHEMBL16120607 0.68 ALDH1A1 (0.44) SMN1; SMN2NFKB1NFKB2RELAKDM4E
SCHEMBL14038741 0.68 — —
SCHEMBL15624861 0.68 MEN1 (0.31) MEN1KMT2ATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019029541-A1 FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR AND USE THEREOF 南京药捷安康生物科技有限公司 2019-02-14 — — WO disclosed
Send feedback